What is Linguistic Validation?
A Plain English Guide
Everything you need to know about LV, cognitive debriefing, and patient voice research — explained by people who actually do it.
If you work in pharmaceutical development, clinical research, or medical translation, you have probably heard the term linguistic validation. But what does it actually mean — and why does it matter so much? This guide breaks it down in plain English, with insight from our partner Mark Gibson, CEO of GRC Health, one of the UK's leading specialists in linguistic validation and patient voice research.
The short answer
Linguistic validation is the process of ensuring that a clinical questionnaire or patient-reported outcome (PRO) measure — originally developed in one language — means exactly the same thing when translated into another.
It is not just translation. It is a structured, regulated research process that tests whether patients in different countries and cultures understand a questionnaire the way it was intended.
Why does it matter?
In clinical trials, pharmaceutical companies use questionnaires to measure how patients feel — their symptoms, quality of life, treatment burden. These are called Clinical Outcome Assessments (COAs) or Patient-Reported Outcomes (PROs).
If a patient in Italy, Japan, or Brazil misunderstands a question — even slightly — the data becomes unreliable. And unreliable data can derail a regulatory submission, delay a drug approval, or worse, lead to a medication being used incorrectly.
“The common seam that runs through all our work is to place the patient at the heart of research, globally.”
Mark Gibson, CEO — GRC HealthWhat does the process involve?
A full linguistic validation process typically includes the following steps:
The original questionnaire is translated into the target language by qualified certified translators with specialist knowledge of the therapeutic area. At TranslationsInLondon, all our translators are subject-matter specialists — never generalists.
Multiple forward translations are reviewed and a single reconciled version is produced, resolving any discrepancies between translators.
The reconciled translation is translated back into the original language by a different translator, to identify any discrepancies or unintended shifts in meaning.
This is where linguistic validation truly distinguishes itself from standard translation. Real patients — native speakers of the target language — are interviewed to check whether they understand each item in the questionnaire the way it was intended. Do the words mean what they're supposed to mean? Are any concepts unclear, ambiguous, or culturally inappropriate?
Findings from cognitive debriefing are reviewed, any necessary changes are made, and the final version is certified as linguistically validated.
A full report is produced documenting every step of the process — ready for submission to the FDA, EMA, or other regulatory bodies. Our partnership with GRC Health means this report is produced to full research standard, not just as a formality.
Translation vs linguistic validation
This is where many people get confused. Translation and linguistic validation are related but fundamentally different activities.
“What is current usage in society may be an ocean away from what the prescriptive traditions say. Translators who want to get into cognitive debriefing have to bridge that gap — and the good ones can.”
Mark Gibson, CEO — GRC HealthThis doesn’t mean translators can’t do linguistic validation. Quite the opposite. Mark argues that translators are naturally equipped for it — they just don’t always know it:
“I don’t think many translators realise how good they are at analysis. You take it for granted — but you’re doing mental algebra every time you translate. And that is a key skill in any kind of research.”
Mark Gibson, CEO — GRC HealthWho needs linguistic validation?
Linguistic validation is required whenever a COA or PRO measure is used in a clinical trial spanning multiple countries or languages. This typically includes:
Pharmaceutical companies running multinational clinical trials requiring FDA or EMA-ready documentation
Biotech companies developing treatments for rare or complex conditions across dispersed global populations
Contract Research Organisations managing multilingual studies requiring validated patient instruments
Medical device companies requiring patient-facing documentation validated across markets
What languages does LV cover?
In principle, any language. In practice, the complexity varies enormously. Major European languages are well served. But clinical trials increasingly require linguistic validation in rarer languages: minority languages, indigenous languages, migrant community languages, and creole languages.
Our partner GRC Health specialises precisely in this area — covering over 250 languages across 198 countries and territories, including Irish, Romansch, Somali (for Swedish populations), Haitian Creole, Tok Pisin, and Krio. TranslationsInLondon supports translation and interpreting across 220+ languages with human translators only.
The silo problem — and why it matters
One of the most important points Mark raised in our recent conversation is that linguistic validation doesn’t exist in isolation. It sits at the intersection of multiple disciplines — translation, sociolinguistics, cognitive science, health literacy, information design, and clinical outcome assessment science.
“Linguistic validation is like Seven Dials in Covent Garden — the roundabout where all of those streets converge. And right now, it talks to nobody. Everyone is working in silos. That’s a shame, because there is incredible scope for cross-pollination.”
Mark Gibson, CEO — GRC HealthAt TranslationsInLondon, our partnership with GRC Health is built precisely on breaking down those silos — combining certified human translation expertise with specialist LV research, to deliver a genuinely end-to-end service for pharma and biotech clients.
How TranslationsInLondon and GRC Health can help
TranslationsInLondon is a certified human translation and interpreting agency with over 15 years of experience in life sciences, pharmaceutical, and medical translation across 220+ languages. We hold ITI Corporate Membership (No. 00030335) and operate a strict no-machine-translation, four-eyes TEP quality process.
In partnership with GRC Health, we now offer a full linguistic validation service — from forward translation and back translation through to cognitive debriefing, regulatory reporting, and eCOA implementation.
Planning a multinational clinical trial? Need linguistic validation for a COA or PRO measure? We’d love to talk.